期刊文献+

泮托拉唑预防危重症患者并发应激性溃疡的临床观察 被引量:2

Clinical study on pantoprazole to prevent the occurrence of stress ulcer in critical patients
原文传递
导出
摘要 目的:观察泮托拉唑对危重症患者预防应激性溃疡的效果。方法:对2008年10月-2011年6月收治的115例危重症患者随机分为研究组(58例)和对照组(57例),对2组患者均给予常规的抢救,另外对研究组患者及时给予泮托拉唑钠治疗,对照组患者给予西咪替丁治疗。观察2组患者肝肾功能、应激性溃疡出血的发生率及死亡率。结果:2组患者治疗前后肝、肾功能差异均无统计学意义(P>0.05)。研究组应激性溃疡的发生率明显低于对照组(P<0.01),死亡率亦明显低于对照组(P<0.05)。结论:泮托拉唑能有效预防危重症患者应激性溃疡的发生,并有助于降低死亡率。 OBJECTIVE To observe the clinical effects of pantoprazole to prevent the occurrence of stress ulcer in critical pa tients. METHODS 115 cases of critical patients treated in our emergency department from October, 2008 to June, 2011 were randomly divided into the experimental group (58 cases) who were trea:ted with pantoprazole on the base of conventional salvage and control group (57 cases) who were treated with cimetidine on the base of conventional salvage. The liver and renal func tions and the incidence of hemorrhage of stress ulcer and mortality were observed between two groups. RESULTS There were no statistic differences of liver function and renal function pre-and post-treatment between two groups(P〉0. 05). The inci dence of hemorrhage of stress ulcer in the experimental group was significantly lower than tbat in the control group (P〈0. (11) and the mortality was also significantly lower than that in the control group (P〈0. 05). CONCLUSION Panloprazole can ef fectively prevent the occurrence of stress ulcer and heln to reduce mortality in critical patients.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第23期1900-1902,共3页 Chinese Journal of Hospital Pharmacy
关键词 泮托拉唑 应激性溃疡 预防 危重症 pantoprazole stress ulcer prevention critical patients
  • 相关文献

参考文献10

  • 1罗彬,于永福.危重症患者应用奥美拉唑预防应激性溃疡的疗效分析[J].新疆医学,2009,38(12):83-84. 被引量:9
  • 2Fennerty MB. Pathophysi01ogy of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression[J]. Crit care Med, 2002, 30:S351-S355.
  • 3许国铭,萧树东,李兆申,黄庭,孙永华,卢亦成,杨兴易,湛先保,赵继宗,王集生.应激性溃疡防治建议[J].中华医学杂志,2002,82(14):1000-1001. 被引量:296
  • 4Perwaiz MK, Posner G, Hammoudeh F, et al. Inappropriateuse of intravenous PPI for stress ulcer prophylaxis in an inner city community hospital[J]. J Clin Med Res, 2010, 2(5):215- 219.
  • 5Ali T, Harty RF. Stress-induced ulcer bleeding in critically ill patients[J]. Gastroenterol Clin North Am, 2009, 38 (2) : 245- 265.
  • 6康凌.脑卒中应激性溃疡的治疗及预防[J].中西医结合心脑血管病杂志,2009,7(12):1506-1508. 被引量:7
  • 7Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units[J]. Am J Health SystPharm, 2007, 64(13) :1396-1400.
  • 8Yu SN, Zhang SQ, Yang CN. Research development on pro- ton pump inhibitors[J]. Chin J New Drugs Clin Rein, 2002, 21(11) : 680- 682.
  • 9Bae DK, Park D, Lee SH, et al. Different antiulcer activities of pantoprazole in stress, alcohol and pylorus ligation-induced ulcer models[J]. Lab Anim Res, 2011, 27(1 ):47-52.
  • 10邹多武,许国铭,李兆申,尹宁.静脉滴注潘妥拉唑对健康人胃内24小时pH影响[J].中华消化杂志,2005,25(4):236-236. 被引量:79

二级参考文献9

共引文献383

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部